Management of post-traumatic stress disorder: a review of anxiety disorders and PTSD

P. P. Skosana; S. Mokhele; J. Andrew; L. A. Zikalala-Mabope; P. P. Lentsoane; V. Abraham

doi:10.36303/SAPJ.0746

Management of post-traumatic stress disorder: a review of anxiety disorders and PTSD

P. P. Skosana^*, S. Mokhele, J. Andrew, L. A. Zikalala-Mabope, P. P. Lentsoane, V. Abraham

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Post-traumatic stress disorder (PTSD) and anxiety disorders are common psychiatric disorders worldwide, with a prevalence of 44.8 million cases in Africa. Their prevelance continues to increase over the years, with the major surge noticed during and after the COVID-19 pandemic. Emerging evidence indicates a strong association between anxiety disorders, including PTSD, with suicidal behaviour. Hence, they both have substantial impact on the individual and society. Thus, a comprehensive understanding of the management of these conditions is crucial. This review provides an overview of PTSD and anxiety disorders, focusing on their pharmacological and non-pharmacological management.

Original language	English
Pages (from-to)	39-45
Number of pages	7
Journal	SA Pharmaceutical Journal
Volume	91
Issue number	4
DOIs	https://doi.org/10.36303/SAPJ.0746
Publication status	Published - 1 Sept 2024

Keywords

Anxiety disorders
anti-anxiety treatment
mental health
post-traumatic stress disorder

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.36303/SAPJ.0746

Cite this

@article{64876795b8d74decb8bfb2c9f5e92cee,

title = "Management of post-traumatic stress disorder: a review of anxiety disorders and PTSD",

abstract = "Post-traumatic stress disorder (PTSD) and anxiety disorders are common psychiatric disorders worldwide, with a prevalence of 44.8 million cases in Africa. Their prevelance continues to increase over the years, with the major surge noticed during and after the COVID-19 pandemic. Emerging evidence indicates a strong association between anxiety disorders, including PTSD, with suicidal behaviour. Hence, they both have substantial impact on the individual and society. Thus, a comprehensive understanding of the management of these conditions is crucial. This review provides an overview of PTSD and anxiety disorders, focusing on their pharmacological and non-pharmacological management.",

keywords = "Anxiety disorders, anti-anxiety treatment, mental health, post-traumatic stress disorder",

author = "Skosana, {P. P.} and S. Mokhele and J. Andrew and Zikalala-Mabope, {L. A.} and Lentsoane, {P. P.} and V. Abraham",

note = "Publisher Copyright: {\textcopyright} Authors.",

year = "2024",

month = sep,

day = "1",

doi = "10.36303/SAPJ.0746",

language = "English",

volume = "91",

pages = "39--45",

journal = "SA Pharmaceutical Journal",

issn = "2221-5875",

publisher = "Medpharm Publications",

number = "4",

}

TY - JOUR

T1 - Management of post-traumatic stress disorder

T2 - a review of anxiety disorders and PTSD

AU - Skosana, P. P.

AU - Mokhele, S.

AU - Andrew, J.

AU - Zikalala-Mabope, L. A.

AU - Lentsoane, P. P.

AU - Abraham, V.

N1 - Publisher Copyright: © Authors.

PY - 2024/9/1

Y1 - 2024/9/1

N2 - Post-traumatic stress disorder (PTSD) and anxiety disorders are common psychiatric disorders worldwide, with a prevalence of 44.8 million cases in Africa. Their prevelance continues to increase over the years, with the major surge noticed during and after the COVID-19 pandemic. Emerging evidence indicates a strong association between anxiety disorders, including PTSD, with suicidal behaviour. Hence, they both have substantial impact on the individual and society. Thus, a comprehensive understanding of the management of these conditions is crucial. This review provides an overview of PTSD and anxiety disorders, focusing on their pharmacological and non-pharmacological management.

AB - Post-traumatic stress disorder (PTSD) and anxiety disorders are common psychiatric disorders worldwide, with a prevalence of 44.8 million cases in Africa. Their prevelance continues to increase over the years, with the major surge noticed during and after the COVID-19 pandemic. Emerging evidence indicates a strong association between anxiety disorders, including PTSD, with suicidal behaviour. Hence, they both have substantial impact on the individual and society. Thus, a comprehensive understanding of the management of these conditions is crucial. This review provides an overview of PTSD and anxiety disorders, focusing on their pharmacological and non-pharmacological management.

KW - Anxiety disorders

KW - anti-anxiety treatment

KW - mental health

KW - post-traumatic stress disorder

UR - http://www.scopus.com/inward/record.url?scp=85203267175&partnerID=8YFLogxK

U2 - 10.36303/SAPJ.0746

DO - 10.36303/SAPJ.0746

M3 - Review article

AN - SCOPUS:85203267175

SN - 2221-5875

VL - 91

SP - 39

EP - 45

JO - SA Pharmaceutical Journal

JF - SA Pharmaceutical Journal

IS - 4

ER -

Management of post-traumatic stress disorder: a review of anxiety disorders and PTSD

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this